The FDA Is Failing – Here’s What Needs To Change
Daniel Aaron explains why premarket review isn’t as effective as it once was, how corporations have leveraged loopholes to skirt around regulations, and how the agency can get back on track.
User Fees And Presidential Intrusion: Why The FDA Isn’t More Effective
Daniel Aaron, an FDA researcher, explains the main hurdles the agency faces and how these obstacles put consumers at risk.
Child Hunger in America: Rising Rates and Promising Solutions
Dr. Sara Bleich, a public health policy expert, reveals the top contributing factors and which communities are most at-risk.
Dropping the Paywalls to Scientific Research
Experts explain how this will affect the public, researchers, and the publishing industry.
Orphan Disease Research: Overcoming Years of Industrywide Neglect
Dr. Stanley Nelson explains how orphan disease research has progressed in the last few decades and why a cure isn’t always the goal.
Lung Cancer and Its Stigma
Most forms of cancer have a built-in constituency of patients, loved ones, and concerned others. Lung cancer patients, instead, are often blamed for their own disease because of its frequent connection with smoking. Patients are often isolated, and research dollars lag behind other, less common cancer killers.
Including Females In Basic Research
Only about a third of research subjects in clinical studies are women this results in poor understanding of how new drugs work on women.
Gender Diversity in Basic Research
Only about a third of research subjects in clinical studies are women. In basic research on animals and cells, female models are even more poorly represented. This results in poor understanding of how new drugs work on women and occasional drug recalls when major side effects are discovered after the fact. Experts discuss why such an imbalance occurs, its …
